Introduction
============

A major goal in current aging research is to understand genetic regulation of aging in humans. However, many recent insights into genetic determinants of aging have been gained from studies with short-lived eukaryotic model systems of aging \[for recent review, see ([@b40])\], which, unlike human beings, are amenable to molecular genetic analysis in the laboratory. Extrapolation of results obtained in lower model organisms identified cellular pathways such as the insulin/IGF pathway ([@b21]; [@b22]), which are conserved in evolution and appear to modulate aging in a variety of organisms including mammals ([@b2]). Although it is very likely that these very same mechanisms also modulate aging in humans, this has not yet been formally proven. Moreover, extrapolating findings in lower model organisms to more complex organisms, such as humans, bears the inherent risk that some pathways, which are less important or absent there, may be overlooked.

To circumvent this potential problem, we applied an alternative strategy, namely to employ human model systems of cellular aging and senescence as the primary screening system. There is now increasing evidence that the appearance of cellular senescence contributes to the aging of tissues, such as the skin ([@b11]; [@b45]), the vascular system ([@b61]; [@b37]; reviewed by [@b13]), and the kidney ([@b35]). We performed genome-wide RNA profiling on several experimental models for cellular senescence, including stress-induced premature senescence (SIPS), replicative senescence, and other distinct forms of cellular aging, as proposed recently ([@b26]; [@b19]) and collected the data in a novel database referred to as the GiSAO (genes involved in senescence, apoptosis, and oxidative stress) database. Comparison of the differential gene expression patterns of the models should in turn unveil distinct novel genetic regulators of cellular aging. Potentially, the information obtained from these experiments, when filtered accordingly, should provide molecular information about highly conserved gene expression patterns related to cellular aging. Because of the genome-wide approach, the data collected from cell types as diverse as those employed herein should also uncover recurrent cellular alterations indicative for hitherto unknown biological aging mechanisms. As a further step in evaluation of the functional role of the individually selected genes, those that were also found to be highly conserved during phylogeny were taken to functional tests in yeast deletion strains thereby monitoring the respective lifespan of the mutant organisms.

Results
=======

Comparative RNA profiling of aging and senescence in human cellular models
--------------------------------------------------------------------------

Accumulation of damage is considered a key factor driving cellular aging, and oxidative stress is a common denominator of stress that induces cellular senescence *in vitro* in a variety of cell types ([@b12]). To identify key transcriptional events preceding senescence induced by oxidative stress, a comprehensive set of human cellular models were subjected to oxidative stress at doses known to elicit a senescence response. The corresponding model systems are referred to as experimental group 1 (EG1) ([Table 1](#tbl1){ref-type="table"}). For comparison, other model systems of cellular aging were also analyzed collectively referred to as experimental group 2 (EG2) ([Table 1](#tbl1){ref-type="table"}). On the one hand, we used models of *in vitro* cellular senescence not triggered by oxidative stress, namely replicative senescence of human umbilical vein endothelial cells (HUVEC) and renal proximal tubular epithelial cells (RPTEC). Similarly, we applied primary foreskin fibroblasts (PFF) in which premature senescence was induced by mitochondrial dysfunction ([@b41]), which is largely independent of oxidative stress ([@b50]). On the other hand, three alternative models of cellular aging (included in experimental group 2, see [Table 1](#tbl1){ref-type="table"}) were also analyzed: first, we compared CD28^−^ and CD28^+^ CD8^+^ T lymphocytes, based on the assumption that the increased percentage of CD28^+^ T cells result from high level cell proliferation and hence represent a form of *in vivo* senescence ([@b47]; [@b24]). Furthermore, we also analyzed differences in the gene expression profiles of mesenchymal stem cells (MSC) obtained from young and old human donors, another system that permits the impact of human donor age on cellular phenotype to be assessed ([@b16]). Finally, we also analyzed gene expression profiles of prostate stromal cells (PrSC), which were driven to transdifferentiate into premature senescent myofibroblasts by TGFβ1, a process considered a hallmark of the aging human prostate, leading to benign prostatic hyperplasia ([@b58]). RNA was prepared from all samples and analyzed on Affymetrix arrays for whole-genome expression profiling. For validation purposes, the expression levels of 22 genes, which were found to be differentially expressed in a high number of individual experiments, were determined by quantitative reverse transcription--PCR (qPCR). Good concordance between data of the microarray and qPCR analyses was obtained. Linear regression yielded an *r*-value of 0.68 and 362 of 380 individual experimental data pairs sitting within the 95% prediction interval ([Fig. S1](#SD1){ref-type="supplementary-material"}).

###### 

Overview microarray experiments: experimental model systems: HUVEC, human umbilical vein epithelial cells; PFF, primary foreskin fibroblasts; PrSC, primary prostatic stromal fibroblasts; RPTEC, renal proximal tubular epithelial cells; CD8, CD8^+^ T lymphocytes; MSC, mesenchymal stem cells; reagents: t-BHP (*tert*-butylhydroperoxide), FCCP (carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone), AMP (adenosine monophosphate); number of array hybridizations/samples; number of array experiments for senescence and oxidative stress; EMBL-EBI Array Express accession number

          Controls   Experimental group 1 (oxidative stress)   Experimental group 2 (cellular aging)                                        
  ------- ---------- ----------------------------------------- --------------------------------------- ------------------------------- ---- -------------
  HUVEC   6          t-BHP                                     2                                       RS                              2    E-MEXP-2283
  PFF     8          ND                                        ND                                      FCCP                            2    E-MEXP-2285
                                                                                                       AMP                             2    
                                                                                                       Oligomycin                      2    
  RPTEC   4          ND                                        ND                                      RS                              1    E-MEXP-2683
                                                                                                       High/low ROS                    1    
  PrSC    10         t-BHP                                     2                                       TGF-β (trans-differentiation)   2    E-MEXP-2167
                                                                                                       20% vs. 3% O~2~                 4    
  CD8     15         t-BHP                                     7                                       CD28^−^/CD28^+^                 4    E-MEXP-2345
  MSC     4          20% vs. 3% O~2~                           2                                       Young vs. old donor             2    E-MEXP-1506
  Total   47                                                   17                                                                      18   

RS, replicative senescence; ND, not determined.

Identification of transcriptional signatures of oxidative stress and cellular aging
-----------------------------------------------------------------------------------

For computational comparison, normalized whole-genome expression profiles from 47 independent experimental samples were established ([Table 1](#tbl1){ref-type="table"}), and hierarchical clustering of the gene expression profiles derived from all experimental human cell models was performed ([Fig. S2](#SD2){ref-type="supplementary-material"}). Differential expression values were calculated and compiled for further analysis by assembling 35 pairs of individual experiments with regard to cellular aging or oxidative stress ([Fig. 1](#fig01){ref-type="fig"}; see also [Table S1](#SD4){ref-type="supplementary-material"}). Considerable resemblance with respect to sets of differentially expressed genes was observed between HUVEC and RPTEC that have undergone replicative senescence, *in vivo* aged CD8 T cells and MSC, as well as in a compilation of these experimental model systems ([Fig. S3](#SD3){ref-type="supplementary-material"}).

![Workflow for candidate gene identification and functional classification. First, gene expression data from 47 microarrays were processed to identify differentially expressed (DE) genes in experimental group 1 (EG1) and experimental group 2 (EG2). The selection of genes for functional classification and pathway analysis, starting from a total of 1566 genes, is shown (left arm). In the right arm of the diagram, the strategy to identify yeast genes for testing in lifespan analysis is depicted.](acel0009-1084-f1){#fig01}

Several methods have been established to identify genes that are differentially expressed in a homologous set of biological replicates. However, complex datasets such as those described herein, which comprise transcriptional profiles from different cell types derived from differently aged, nonrelated human individuals, often show highly variable transcript levels with regard to the expression of individual genes ([@b28]; [@b46]; [@b54]; [@b25]). This can be either because of variant genetic background or the redundant use of closely related homologous genes. Therefore, we employed a value counting method.

The number a particular gene was found under- or overexpressed was counted, and the list of all genes was sorted according to occurrence. Using this methodology, we identified 586 probe sets representing 484 genes across EG1 with differential expression (DE) higher than ±1.5-fold in more than 50% of individual pair-wise comparisons, and 1423 probe sets representing 1087 genes across EG2, again with the same criteria of DE \> ±1.5 in \> 50% of experiments, whereas 180 probe sets representing 155 genes were present in both data sets. With respect to a cumulative binomial distribution (CBD), we additionally calculated *P*-values together with the corresponding *q*-values ([Table S2](#SD5){ref-type="supplementary-material"}) yielding a probability of 0.12 for any probe set to be differentially expressed with senescence and a probability of 0.11 for a probe set to be differentially expressed with oxidative stress. The *q*-values were ≤ 0.0030 in both EG1 and EG2, and *P*-values were ≤ 0.000028 in EG1 and ≤ 0.000085 in EG2 ([Table S2](#SD5){ref-type="supplementary-material"}). When evaluating both experimental groups along these lines, we revealed a set of 335 candidate genes with DE \> ±1.5 in at least 18 pair-wise comparisons ([Table S3](#SD6){ref-type="supplementary-material"}).

The highest overall score (with most occurrences of DE) was observed for *PAF* (PCNA associated factor) ([Table 2A](#tbl2){ref-type="table"}) ([@b65]), a gene recently reported to be involved in DNA repair in HeLa cells ([@b57]). Another top scoring gene was SKP2 ([Table 2A](#tbl2){ref-type="table"}), encoding a regulatory subunit of an ubiquitin ligase complex, which was recently identified as playing a key role in setting the threshold for stress-induced cellular senescence ([@b27]). Several additional genes were identified with high scores, such as SLC1A4, a member of the solute carrier family 1 ([Table 2A](#tbl2){ref-type="table"}), which so far have not been linked to the senescent phenotype. Of note, four genes involved in the regulation of transcription (BHLHB2, TCF8, RUNX1, and TCEA3) were included in the top 15 genes common to both experimental groups ([Table 2A](#tbl2){ref-type="table"}).

###### 

\(A\) Genes that were found differentially expressed with highest occurrence in both experimental groups, (B) group 1 (oxidative stress), (C) group 2 (cellular aging)

  Symbol      Description                                                           Unigene     GenBank     EG1 up   EG1 down   EG2 up   EG2 down   EG1 + EG2DE
  ----------- --------------------------------------------------------------------- ----------- ----------- -------- ---------- -------- ---------- -------------
  \(A\)                                                                                                                                             
  KIAA0101    KIAA0101/PAF                                                          Hs.81892    NM_014736   7        7          6        7          27
  APOBEC3G    Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G   Hs.660143   NM_021822   0        10         8        8          26
  MEST        Mesoderm-specific transcript homolog (mouse)                          Hs.270978   NM_002402   4        5          8        8          25
  RRM2        Ribonucleotide reductase M2 polypeptide                               Hs.226390   BE966236    7        5          4        9          25
  SYDE2       Synapse defective 1, Rho GTPase, homolog 2 (*C. elegans*)             Hs.718601   N90719      7        5          5        8          25
  TXNIP       Thioredoxin interacting protein                                       Hs.715525   AA812232    2        9          7        7          25
  BHLHB2      Basic helix-loop-helix domain containing, class B, 2                  Hs.719093   NM_003670   5        6          10       3          24
  BICD1       Bicaudal D homolog 1 (*Drosophila*)                                   Hs.505202   BC010091    10       3          7        4          24
  CYP51A1     Cytochrome P450, family 51, subfamily A, polypeptide 1                Hs.417077   U40053      10       1          10       3          24
  HMGCS1      3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)            Hs.397729   NM_002130   9        3          9        3          24
  SKP2        S-phase kinase-associated protein 2 (p45)                             Hs.23348    BC001441    5        9          3        7          24
  SLC1A4      Solute carrier family 1 (neutral amino acid transporter), member 4    Hs.654352   W72527      6        1          11       6          24
  TCF8        Transcription factor 8 (represses interleukin 2 expression)           Hs.282113   NM_030751   6        6          6        6          24
  C20orf129   Chromosome 20 open reading frame 129                                  Hs.472716   BC001068    11       1          7        4          23
  CD302       CD302 antigen                                                         Hs.130014   NM_014880   7        4          6        6          23
  IFI44L      Interferon-induced protein 44-like                                    Hs.389724   NM_006820   3        7          8        5          23
  PDGFD       Platelet derived growth factor D                                      Hs.352298   NM_025208   5        4          6        8          23
  RUNX1       Runt-related transcription factor 1 (acute myeloid leukemia 1)        Hs.675708   BU789637    2        9          9        3          23
  TCEA3       Transcription elongation factor A (SII), 3                            Hs.446354   AI675780    2        8          4        9          23
  TSPAN2      Tetraspanin 2                                                         Hs.310458   AI743596    4        6          7        6          23

  Symbol      Description                                                                         Unigene     GenBank     EG1 up   EG1 down   EG1 DE
  ----------- ----------------------------------------------------------------------------------- ----------- ----------- -------- ---------- --------
  \(B\)                                                                                                                                       
  KIAA0101    KIAA0101/PAF                                                                        Hs.81892    NM_014736   7        7          14
  RRM2        Ribonucleotide reductase M2 polypeptide                                             Hs.226390   BC001886    8        6          14
  SKP2        S-phase kinase-associated protein 2 (p45)                                           Hs.23348    BC001441    5        9          14
  TRPV2       Transient receptor potential cation channel, subfamily V, member 2                  Hs.279746   NM_015930   4        10         14
  BICD1       Bicaudal D homolog 1 (Drosophila)                                                   Hs.505202   BC010091    10       3          13
  EIF4A2      Eukaryotic translation initiation factor 4A, isoform 2                              Hs.518475   AI332397    10       3          13
  NQO1        NAD(P)H dehydrogenase, quinone 1                                                    Hs.406515   NM_000903   9        4          13
  C20orf129   Chromosome 20 open reading frame 129                                                Hs.472716   BC001068    11       1          12
  CASP1       Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)   Hs.2490     U13699      2        10         12
  CCNB2       Cyclin B2                                                                           Hs.194698   NM_004701   5        7          12
  CIRBP       Cold-inducible RNA-binding protein                                                  Hs.634522   AL565767    8        4          12
  CKAP2       Cytoskeleton-associated protein 2                                                   Hs.444028   NM_018204   11       1          12
  CYBA        Cytochrome *b*-245, alpha polypeptide                                               Hs.513803   NM_000101   3        9          12
  DAAM1       Disheveled-associated activator of morphogenesis 1                                  Hs.19156    AA890373    8        4          12
  EGR1        Early growth response 1                                                             Hs.326035   NM_001964   6        6          12
  EIF5A       Eukaryotic translation initiation factor 5A                                         Hs.534314   NM_001970   11       1          12
  ERRFI1      ERBB receptor feedback inhibitor 1                                                  Hs.658370   AW612461    7        5          12
  FBXO9       F-box protein 9                                                                     Hs.216653   AK095307    8        4          12
  HMGCS1      3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)                          Hs.397729   NM_002130   9        3          12
  IGFBP3      Insulin-like growth factor binding protein 3                                        Hs.450230   BF340228    4        8          12

  Symbol     Description                                                           Unigene     GenBank     EG2 up   EG2 down   EG2 DE
  ---------- --------------------------------------------------------------------- ----------- ----------- -------- ---------- --------
  \(C\)                                                                                                                        
  SLC1A4     Solute carrier family 1 (neutral amino acid transporter), member 4    Hs.654352   BF340083    11       7          18
  ARRB1      Arrestin, beta 1                                                      Hs.503284   BE207758    8        9          17
  APOBEC3G   Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G   Hs.660143   NM_021822   8        8          16
  MEST       Mesoderm-specific transcript homolog (mouse)                          Hs.270978   NM_002402   8        8          16
  CTSC       Cathepsin C                                                           Hs.128065   AI246687    10       5          15
  METTL7A    Methyltransferase like 7A                                             Hs.716437   NM_014033   10       5          15
  GLIPR1     GLI pathogenesis-related 1 (glioma)                                   Hs.205558   AV682252    7        8          15
  RAB27B     RAB27B, member RAS oncogene family                                    Hs.25318    BF438386    11       4          15
  TRIB3      Tribbles homolog 3 (Drosophila)                                       Hs.516826   NM_021158   10       5          15
  ABL2       v-abl Abelson murine leukemia viral oncogene homolog 2                Hs.159472   AK025877    9        5          14
  EIF4EBP1   Eukaryotic translation initiation factor 4E binding protein 1         Hs.411641   AB044548    8        6          14
  ETV1       ets variant gene 1                                                    Hs.22634    BE881590    9        5          14
  IFIT3      Interferon-induced protein with tetratricopeptide repeats 3           Hs.714337   AI075407    7        7          14
  KLF9       Kruppel-like factor 9                                                 Hs.150557   AI690205    3        11         14
  MCC        Mutated in colorectal cancers                                         Hs.593171   BE967311    3        11         14
  PDGFD      Platelet derived growth factor D                                      Hs.352298   NM_025208   6        8          14
  PHGDH      Phosphoglycerate dehydrogenase                                        Hs.487296   NM_006623   4        10         14
  PHLDA1     Pleckstrin homology-like domain, family A, member 1                   Hs.602085   AK026181    10       4          14
  PTGS2      Prostaglandin-endoperoxide synthase 2                                 Hs.196384   NM_000963   8        6          14
  RAB1A      RAB1A, member RAS oncogene family                                     Hs.709257   BG530481    4        10         14

When both experimental groups were treated separately, the highest scoring genes (with most occurrences of DE) for experimental group 1 (oxidative stress) were genes involved in regulating cell proliferation, such as RRM2, cyclin B2, EGR1, and IGFBP-3 ([Table 2B](#tbl2){ref-type="table"}), consistent with the induction of rapid growth arrest by oxidative stress ([@b7]). In addition, several genes were identified for which a role in stress-induced senescence was not known before, such as the translation initiation factors EIF4A and EIF5A ([Table 2B](#tbl2){ref-type="table"}). The highest scoring genes (with most occurrences of DE) for experimental group 2 (cellular aging) are shown in [Table 2C](#tbl2){ref-type="table"}. Surprisingly, the top 15 genes in this group were distinct from the top scorers obtained in experimental group 1. Moreover, most of the genes identified in this approach were not previously associated with cellular senescence. Hence, this list of genes may contain novel information about potential unidentified regulators of cellular aging, probably including genes that are relevant for cellular aging *in vivo*. The regulation of selected genes was also addressed at the protein level. On the one hand, selected genes were analyzed across all cellular model systems. For example, protein levels were determined for the conserved candidate gene EZH2 (DE = 19; [Table S2](#SD5){ref-type="supplementary-material"}), coding for a histone methyltransferase that plays a major role in epigenetic regulation of senescence ([@b3].). Consistent with data obtained by RNA profiling, EZH2 protein level was considerably reduced in senescent RPTEC and HUVEC, as well as in PFF after treatment with adenosine monophosphate (AMP) and carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) but not oligomycin ([Fig. 2A](#fig02){ref-type="fig"}). EZH2 levels were not significantly regulated in MSC, PrSC, and CD8 T lymphocytes ([Fig. 2B, C](#fig02){ref-type="fig"}) consistent with the results of RNA profiling. Additional protein analyses were performed for relevant proteins selectively in particular model systems. Thus, we confirmed by Western blot upregulation of IGFBP-3 in trans-differentiated PrSC and MSC grown in a hyperoxic atmosphere ([Fig. 2B](#fig02){ref-type="fig"}). In additional experiments, we confirmed the upregulation of IGFBP-3 and IGFBP-6 in cellular supernatants by ELISA and the downregulation of IGF1R in CD8^+^CD28^−^ T lymphocytes by antibody assisted flow cytometry (data not shown).

![Western blot analysis. Cell lysates were prepared from various model systems employed in this study: young and senescent human umbilical vein endothelial cells and renal proximal tubular epithelial cells, respectively; PFF treated with FCCP, AMP, and oligomycin for three days (A); mesenchymal stem cells cultured at atmospheric conditions of 3% or 20% oxygen; prostate stromal cells treated with either basic fibroblast growth factor (bFGF) or transforming growth factor beta 1 (TGFβ1) (B); CD8 T cells either isolated from a young or an elderly donor and sorted with respect to CD28 (C); Proteins were analyzed by immunoblotting using antibodies to EZH2, ALDH2, cystathionine beta-synthase, and IGFBP3, as indicated. For loading control, antibodies to β-actin and GAPDH were used as indicated.](acel0009-1084-f2){#fig02}

Pathway analysis
----------------

To analyze the large amount of gene expression data in a user-friendly way and for optimal data mining, a database was constructed referred to as the GiSAO database ('Genes Involved in Senescence, Apoptosis and Oxidative stress' ([@b26]); for details, see 'Experimental procedures'). Currently, more than a hundred whole-genome array data sets fulfilling MIAME criteria from cellular aging model systems were deposited by this consortium in the GiSAO database (<https://gisao.genome.tugraz.at/gisao_web/>), also including the datasets of miRNA expression published recently ([@b19]). To identify principal biological processes associated with age-related transcriptional changes, we first evaluated top-ranked genes via Pathway Explorer ([@b36]), a web-accessible tool that allows life scientists to infer the biological meaning behind large gene lists. Pathway analysis for genes that are DE in both experimental groups highlighted the p53 signaling pathway, apoptosis, and cell cycle regulation as the most relevant pathways. The general importance of pathways controlling cell proliferation and cell death for cellular senescence is well established ([@b33]). Thus, these observations validate our experimental approach. The analysis identified additional pathways that were significantly overrepresented (*P* \< 0.001) in the group of differentially regulated genes, which have not previously been linked to cellular senescence, such as cholesterol biosynthesis, IL-18 signaling, and nitrogen metabolism ([Table 3](#tbl3){ref-type="table"}).

###### 

Pathway analysis: functional classification of genes that are differentially expressed in experimental groups 1, 2 or both, using Pathway Explorer ([@b36]; available online: <https://pathwayexplorer.genome.tugraz.at/>), gene number attributed to pathway, *P*-values were calculated from complete expression value dataset (54 675 probe sets) with Fisher's exact test, where gene numbers are given, all *P*-values are \< 0.05

  Pathway                                            Gene number EG1                     Gene number EG2                     Gene number EG1 + EG2
  -------------------------------------------------- ----------------------------------- ----------------------------------- -----------------------------------
  Apoptosis                                          17                                  39                                  7
  Cell cycle                                         15                                  27                                  7
  p53 signaling pathway                              7                                   32                                  7
  Cell proliferation                                 [\*](#tf3-1){ref-type="table-fn"}   32                                  7
  Chromosome                                         14                                  [\*](#tf3-1){ref-type="table-fn"}   5
  Lipid biosynthesis                                 13                                  [\*](#tf3-1){ref-type="table-fn"}   4
  Cytokinesis                                        10                                  [\*](#tf3-1){ref-type="table-fn"}   5
  Pyrimidine metabolism                              9                                   [\*](#tf3-1){ref-type="table-fn"}   3
  G1 to S cell cycle control                         8                                   [\*](#tf3-1){ref-type="table-fn"}   3
  mRNA metabolism                                    10                                  [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}
  ATP-dependenthelicase activity                     9                                   [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}
  Fatty acid metabolism                              9                                   [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}
  mRNA processing                                    9                                   [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}
  D4-GDI signaling pathway                           7                                   [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}
  DNA replication                                    7                                   [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}
  MAPK signaling pathway                             [\*](#tf3-1){ref-type="table-fn"}   36                                  [\*](#tf3-1){ref-type="table-fn"}
  Extracellular matrix                               [\*](#tf3-1){ref-type="table-fn"}   33                                  [\*](#tf3-1){ref-type="table-fn"}
  Focal adhesion                                     [\*](#tf3-1){ref-type="table-fn"}   29                                  [\*](#tf3-1){ref-type="table-fn"}
  Enzyme inhibitor activity                          [\*](#tf3-1){ref-type="table-fn"}   28                                  [\*](#tf3-1){ref-type="table-fn"}
  Cytokine--cytokinereceptor interaction             [\*](#tf3-1){ref-type="table-fn"}   27                                  [\*](#tf3-1){ref-type="table-fn"}
  Cell growth                                        [\*](#tf3-1){ref-type="table-fn"}   24                                  [\*](#tf3-1){ref-type="table-fn"}
  Cell surface receptor linked signal transduction   [\*](#tf3-1){ref-type="table-fn"}   24                                  [\*](#tf3-1){ref-type="table-fn"}
  Wnt signaling pathway                              [\*](#tf3-1){ref-type="table-fn"}   24                                  [\*](#tf3-1){ref-type="table-fn"}
  Cholesterol biosynthesis                           [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}   3
  Fructose and mannose metabolism                    [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}   3
  IL 18 signaling pathway                            [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}   2
  Nitrogen metabolism                                [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}   3
  Synthesis and degradation of ketone bodies         [\*](#tf3-1){ref-type="table-fn"}   [\*](#tf3-1){ref-type="table-fn"}   2

No genes were found for particular pathway or *P* \> 0.05.

Pathway data source: KEGG pathway database (<http://www.genome.jp/kegg/pathway.html>), GenMapp (<http://www.genmapp.org/>), Biocarta (<http://www.biocarta.com/genes>).

Pathway analysis was also separately applied to experimental groups 1 and 2. For genes differentially expressed in experimental group 1 (oxidative stress), the highest ranked clusters were related to the regulation of apoptosis and cell cycle, in particular the G1/S transition. Additionally, chromosome maintenance, lipid biosynthesis, D4-GDI signaling, and DNA replication scored highly significant (*P* \< 0.001). Among the genes differentially expressed in experimental group 2, top clusters related to apoptosis, MAPK signaling, and extracellular matrix. In addition, highly significant scores (*P* \< 0.001) were observed for p53 signaling, enzyme inhibitor activity, cell cycle regulation, cell surface receptor linked signal transduction, and cell growth. In this group, we also noted a high representation of the Wnt signaling pathway and cytokine--cytokine receptor interactions, two pathways previously linked with cellular senescence ([@b64]; [@b1]; [@b10]); however, in both cases, statistical significance was rather weak.

Functional validation of candidate genes by lifespan analysis in yeast mutants
------------------------------------------------------------------------------

Next, potential homologues of the human candidate genes were identified in the genome of budding yeast, *Saccharomyces cerevisiae*. To this end, an extended list of human genes was compiled with differential expression (DE \> 1.5) in at least 6 of 17 experiments in experimental group 1 or at least 6 of 18 experiments in experimental group 2 ([Fig. 1](#fig01){ref-type="fig"}). Both upregulated and downregulated genes were considered. Starting with a total of 6750 human genes, 553 yeast orthologs were identified, of which only the nonessential genes were considered for further analysis. For the top ranking human genes, 93 nonessential yeast orthologs were identified ([Table S4](#SD7){ref-type="supplementary-material"}). Subsequently, functional tests regarding long-term proliferation were performed, and the viability of the respective mutant yeast strain was validated. The deletion mutants of the corresponding *S. cerevisiae* homologues were obtained from the EUROSCARF knockout strain collection. A panel of yeast mutant cells in stationary phase was analyzed by chronological lifespan experiments ([@b29]; [@b42]) involving 22-day culturing in stationary phase as described ([@b15]; [@b20]). As control, wild-type strains were also analyzed, which have a mean lifespan of about 11 days under these conditions ([@b15]; [@b20]). Twenty-two days after the start of the experiment, the wild-type strain completely ceased growth and was all found dead. The 93 selected yeast mutant strains displayed significantly different survival rates ([Table 4](#tbl4){ref-type="table"}), ranging from drastic lifespan shortening to lifespan extension relative to wild-type cells. For a more detailed analysis, the lifespan data were repeated for the nine most short-lived strains containing mutations in ATG18, GCM5, KGD1, LYS69, MSW1, NCR1, TIM1, RAD27, and SHM1. Lifespan shortening relative to the wild-type was highly reproducible ([Fig. 3A](#fig03){ref-type="fig"}), with the disruption of KGD1, MSW1, and TIM1 having the greatest effect on lifespan, suggesting that these genes play important roles for survival in stationary culture. Similarly, yeast mutants with extended lifespan were also identified ([Table 4](#tbl4){ref-type="table"}), and a significant extension of lifespan was obtained for the mutants ΔCYS4, ΔALD4, and ΔPDX3 ([Fig. 3B](#fig03){ref-type="fig"}). Whereas yeast strains mutated in UBC12 and PAS3 showed a trend for extended lifespan, this did not reach statistical significance. The *CYS4* gene encodes a cystathionine beta-synthase involved in the first step of cysteine biosynthesis while Ald4p is the major aldehyde dehydrogenase isoform. *PDX3*, encoding pyridoxine (pyridoxamine) 5′-phosphate oxidase, is involved in the salvage pathway of pyridoxal 5′-phosphate. As a first step to address the relevance of the human orthologs in our cellular senescence models, expression and regulation of ALDH2 and cystathionine beta-synthase (CBS) was analyzed by Western blot. ALDH2 protein level was upregulated in senescent RPTEC and in FCCP-treated PFF ([Fig. 2](#fig02){ref-type="fig"}), but remained unchanged in the other experimental models ([Fig. 2](#fig02){ref-type="fig"} and data not shown). Cystathionine beta-synthase protein level was downregulated with senescence in both HUVEC and RPTEC, as well as in AMP-treated PFF ([Fig. 2](#fig02){ref-type="fig"}), consistent with the data obtained by RNA profiling. In contrast, CBS was not significantly regulated in the other cellular model systems (data not shown). Together, the data suggest that the levels of ALDH2 and CBS gene products are indeed regulated by the various treatments, in most cases reflecting the differential expression values as elucidated by our initial genomic screening method. The pattern of regulation is complex in both cases, and more work is required to understand the exact contribution of these genes to cellular senescence.

###### 

Effects on chronological aging observed in 93 single deletion strains: deletion strains were assigned to five categories, depending on the effects on survival during aging when compared to the wild-type

  Survival during chronological aging (compared to WT)   Single deletion of
  ------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strongly reduced (\< 50% of wt)                        *KGD1*, *SOD2*, *RPL31A*, *NCR1*, *LYS9*, *SHM1*, *GCN5*, *HAP3*, *PIM1*, *PRY1*, *ATG18*, *CYC1*, *RPL13B*, *MSW1*, *RAD27*, *YDC1*, *TIF3*
  Slightly reduced(\> 50% and \< 85%)                    *CLB1*, *CLB2*, *APM1*, *SYM1*, *IDP2*, *GSY2*, *ALT2*, *SIZ1*, *TIF1*, *TIF2*, *NPL3*, *PTC5*, *RNR3*, *ERG24*, *MRT4*, *MSH6*, *NUP170*, *HAT1*, *INP53*, *SSO1*, *TWF1*, *SGT2*, *LHS1*, *RPL37A*, *ARF1*, *DHP5*, *CHL1*, *TRX1*, *UBC8*, *CHD1*, *SPE2*, *HRT3*, *MRE11*, *MSH2*, *DBP1*, *SSN3*, *SSF1*
  Not affected(same as wt ±15%)                          *HTA2*, *AIP1*, *HXK1*, *SER1*, *YPK2*, *UBC11*, *ENO1*, *RPL22B*, *RPL43B*, *PEX13*, *REV3*, *SYG1*, *MSH5*, *ERP6*, *TPK1*, *PER1*, *URA2*, *SLH1*, *CHK1*, *ALD5*, *CAF40*
  Slightly increased (\> 115% and \< 150%)               *MAD2*, *PCH2*, *YTA7*, *PHO89*, *UGA1*,*DIE2*, *CAF17*, *HMT1*, *ALG5*, *SSA3*, *LSB6*
  Strongly increased (\> 150%)                           *CYS4*, *DNF1*, *ALD4*, *PDX3*, *RNH201*, *UBC12*, *PRS3*

![Functional analysis of selected candidate genes in yeast. Lifespan data for the nine yeast mutants with shortest lifespan (A) and for the seven mutants with lifespan extension (B) are shown. (\**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001).](acel0009-1084-f3){#fig03}

Discussion
==========

The here presented analysis has identified gene expression signatures of cellular aging, which are conserved between different human tissues. The experimental design was based on the assumptions that (i) genes that are differentially regulated in human cellular aging and senescence are trustworthy candidates for modulators of aging and that (ii) the ability of a certain gene to restrict lifespan in yeast suggests that this gene has a role in modulating the rate of aging that potentially extends beyond yeast. This analysis revealed several genes and molecular pathways already known to be involved in aging, thereby validating the screen. In addition, a reasonable number of novel genes and a few novel pathways were identified that have not been linked to aging before. Based on these findings, new experimental approaches to study human aging will become possible.

Model systems for cellular aging
--------------------------------

According to current hypotheses, aging at the cellular level contributes significantly to organismic aging, and for a better understanding of human aging, cellular model systems are indispensible ([@b5]; [@b55; @b56]). Several model systems for cellular aging have been developed, and a representative selection of these models was applied for the present study: replicative senescence, a process of cellular aging *in vitro* that is primarily driven by telomere erosion, is a classic experimental system considered relevant for the aging of tissues with high regenerative potential ([@b17]). In addition to replicative senescence, most if not all primary human cells can be driven into premature senescence by various stressors, in a process which does not necessarily involve telomere shortening. It is assumed that SIPS is relevant for aging of both mitotic and postmitotic tissues ([@b55; @b56]). The importance of SIPS for *in vivo* aging is supported by the fact that SIPS can be induced *in vitro* by factors that are well-known risk factors for age-associated degeneration of the corresponding tissue *in vivo*. For example, vascular endothelial cells undergo SIPS in response to oxidative stress, high glucose, shear stress, and incubation with oxidized LDL, all of which are known risk factors for age-associated vascular dysfunction and disease ([@b14]; [@b18]). Three additional model systems of cellular aging, with a particular focus on aging *in vivo*, were included in the analysis: first, we compared CD28^−^ and CD28^+^ CD8^+^ T lymphocytes, described as one of the rare models for *in vivo* senescence ([@b47]; [@b24]); second, we compared MSC freshly obtained from young and old human donors ([@b16]); finally, PrSC were included, which can be transdifferentiated into premature senescent myofibroblasts, a process considered a hallmark of the aging human prostate ([@b58]). These cellular model systems were developed by the participating laboratories and are not easily available elsewhere. Information on genetic regulators of cellular aging obtained from these systems is considered particularly valuable, given the scarcity of knowledge on molecular genetic processes involved in human aging.

The GiSAO database
------------------

Other resources have been created to systematically compare the influence of the genome on aging processes. Of note, the Human Ageing Genomic Resources (HAGR) ([@b30]) represent a systematic collection of genomic data relevant for aging processes. It consists of the database GenAge featuring genes associated with aging and longevity in short-lived model organisms and humans, and AnAge, a database of aging in animals, featuring information on aging processes in over 4000 animal species ([@b31; @b32]). The GiSAO database established in the current communication focuses on genetic regulation of aging at the cellular level, based on human gene expression data, and allows the identification of evolutionarily conserved regulators of cellular aging. In our view, information contained in the GiSAO database conveniently complements the data on organismic aging available in the HAGR. We have compared data sets in both studies. Indeed, several genes with a high score in the meta-analysis described earlier ([@b31; @b32]), including TXNIP, S100A4, and MT1F, featured prominently in our analysis described here ([Table S3](#SD6){ref-type="supplementary-material"}). In turn, 15 genes taken from [Table S3](#SD6){ref-type="supplementary-material"}, including IGFBP-3, PTGS2, EGR1, FOS, ATM, DDIT3 (DE ≥ 20) are also highlighted as potential regulators of aging in the HAGR database. Hence, future attempts to link both resources are warranted.

Confirmation of known association of genes/pathways with aging
--------------------------------------------------------------

Several of the pathways highlighted in the current analysis have been associated with aging in cellular senescence and/or animal models before. For example, apoptosis regulation ([@b4]), MAP kinase signaling ([@b34]), p53 signaling ([@b66]), control of cell proliferation and cell cycle ([@b6]), cytokine--cytokine receptor interaction ([@b9]), and Wnt signaling ([@b64]) are thought to contribute to cellular senescence and aging. In addition, several of the genes identified in the unbiased screen described here were found to play important roles as regulators of senescence. Thus, Skp2 ([@b27]) and EZH2 ([@b3]) are known to contribute to the senescence response in various cell types. Work in the consortium established the genes coding for IGFBP-3 ([@b23]; [@b39]), glutaminase ([@b60]), and IGFBP-6 (Micutkova *et al.*, submitted) as functional regulators of cellular senescence. The prominent appearance of these pathways and genes in our screening results serves as positive control and indicates that the screening procedure was adequate.

Identification of novel genes/pathways related to aging
-------------------------------------------------------

Some interesting human genes, e.g. genes related to cholesterol biosynthesis, came up in our screen, which have not been related to aging before. Similarly, genes related to the regulation of focal adhesion, extracellular matrix, mRNA metabolism, fatty acid metabolism, and lipid biosynthesis were not known to be associated with aging processes. Although many of these genes could not be analyzed in yeast because there are no obvious orthologs in the yeast genome, these observations will stimulate future research on the role of the respective genes/pathways both in short-lived model organisms of aging and in human cellular aging.

Using extension of the chronological lifespan in yeast, which depends far less on cell-to-cell communication compared to higher organisms, as an additional screening tool, we expected to identify primarily basic cell autonomous mechanisms of aging. In this category, three genes particularly stood out, as follows: (i) ALD4, the major (mitochondrial) aldehyde dehydrogenase isoform, which is involved in the degradation of various amino acids and fatty acids in yeast, whereas the human homolog ALDH2 acts in the major oxidative pathway of alcohol metabolism; (ii) CYS4, cystathionine beta-synthase, that carries out the first committed step in cysteine biosynthesis, whereas the human homolog CBS catalyzes the conversion of homocysteine to cystathionine, the first step in the trans-sulfuration pathway; (iii) Pyridoxine (pyridoxamine) phosphate oxidase (PDX3), known to play a role in the synthesis of pyridoxal 5′-phosphate in yeast, similar to the human homolog pyridoxamine 5′-phosphate oxidase (PNPO), which catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5′-phosphate, also known as vitamin B6. Interestingly, CBS requires vitamin B6 as a cofactor for the conversion of homocysteine to cystathionine in human cells, suggesting that CBS and PNPO influence aging via the same pathway. Importantly, none of these pathways have been linked to aging before, and future studies are required to address the role of these proteins in multi-cellular aging model systems including humans. As a first step to validate their relevance in human cellular senescence, expression levels were analyzed in cellular extracts where antibodies were available. We found differential regulation of ALDH2 and CBS protein levels in several of our model systems ([Fig. 2](#fig02){ref-type="fig"}). Accordingly, further studies are warranted to determine their role in cellular senescence.

Experimental procedures
=======================

Cell isolation, cultivation, and characterization
-------------------------------------------------

Human diploid fibroblasts from foreskin were seeded in 10-cm dishes at a density of 200,000 cells per dish and treated in parallel with the following compounds: untreated, vehicle treated (ethanol), oligomycin (8 μmol L^−1^ final concentration), FCCP (3 μmol L^−1^ final concentration), and AMP (3 μmol L^−1^ final concentration). Every day, medium was replaced and inhibitory compounds freshly added. This treatment leads to premature senescence within 14 days (data not shown, see also ([@b49; @b50]; [@b67]). RNA was prepared after 72 h of incubation and analyzed by RNA profiling as described earlier.

Human umbilical vein endothelial cells were isolated from human umbilical veins and cultured in Endothelial Cell Basal Medium (Lonza, Basel, Switzerland) supplemented with endothelial cell growth medium (EGM) Single Quots (Lonza), containing hEGF 0.5 mL, hydrocortisone 0.5 mL, GA-1000 0.5 mL, BBE 2.0 mL, and FBS 10.0 mL. The cells were subcultured by trypsination with trypsin-EDTA (Gibco Life Technologies, Vienna, Austria), seeded on cell culture dishes coated with 0.2% gelatine and grown at 37°C at ambient atmosphere containing 5% CO~2~. Cells were passaged at a ratio of 1:5 in regular intervals. At later passages, the splitting ratio was reduced to 1:3 and 1:2, respectively. Cells were passaged before reaching 70--80% confluence. Population doublings (PDL) were estimated using the following equation: *n*= (log10 *F* − log10 *I*)/0.301 (where *n* is the population doublings, *F*, number of cells at the end of one passage, and *I*, number of cells that were seeded at the beginning of one passage). After 50 PDL, the cells reached growth arrest, and the senescent phenotype was verified by staining for senescence-associated beta galactosidase, which was positive for ≥ 95% of cells.

Human primary PrSC were established and trans-differentiation induced by TGF-beta1 treatment, as described ([@b58]). Briefly, PrSC were derived from prostate cancer patients who have not received hormonal therapy (*n* = 3, age 65--72) after obtaining written informed consent. After radical prostatectomy and inspection by the pathologist, two tissue wedges showing no histological signs of malignancy were removed from the transition zone. These explants were minced into organoids of ∼ 1 mm^3^ and seeded on uncoated plastic material in stromal cell growth medium containing insulin, human basic fibroblast growth factor, 5% fetal calf serum, and gentamycin and amphotericin-B as antibiotics (SCGM; Lonza). Explants were maintained at 37°C in a humidified atmosphere of 5% CO~2~. These conditions produce a homogeneous fibroblast cell population after 7 days of culture. When cells reached 70% confluence, they were split at a 1:3 ratio using trypsin-EDTA to expand the population. In all experiments, cells of passage 2--4 were used directly from culture (not previously frozen).

Renal proximal tubular epithelial cells were cultivated as recently reported ([@b62]). In brief, within 24 h after surgery, tissue from the renal cortex was fragmented and incubated at 37°C for 15--20 min in DMEM/Ham's F12 (1:1) (Biochrom KG, Berlin, Germany) containing 1 mg mL^−1^ collagenase type IV (PAN-BioTech GmbH, Aidenbach, Germany) and 1 mg mL^−1^ trypsin-inhibitor (Sigma, Vienna, Austria). After being passed through a 105-μm nylon mesh, the filtrate was centrifuged, washed twice with phosphate-buffered saline (PBS), resuspended in medium, and dispensed into roux-flasks (Nunc, Wiesbaden, Germany). 24 hours thereafter medium was changed. The initial passage of confluent cells after 3--5 days was considered as PDL zero. Cells were passaged (1:2 to 1:4) at confluence, using 0.25% trypsin/0.02% EDTA, which was inactivated with 1 mg mL^−1^ trypsin-inhibitor. Cumulative PDL was calculated as a function of passage number and split ratio (4). Medium consisted of DMEM/Ham's F12 (1:1) supplemented with 4 m[m l]{.smallcaps}-glutamine, 10 m[m]{.smallcaps} HEPES buffer, 5 p[m]{.smallcaps} tri-iodothyronine, 10 ng mL^−1^ recombinant human EGF, 3.5 μg mL^−1^ ascorbic acid, 5 μg mL^−1^ transferrin, 5 μg mL^−1^ insulin, 25 ng mL^−1^ prostaglandin E1, 25 ng mL^−1^ hydrocortisone, and 8.65 ng mL^−1^ sodium selenite (all from Sigma). After 24 PDL, the cells reached growth arrest, and the senescent phenotype was verified by staining for senescence-associated beta galactosidase, which was positive for ≥ 95% of cells. Cells at intermediate passage could be divided into two groups concerning their redox status, as monitored by dichlorofluorescein diacetate (DCFDA) staining. To address the significance of this distinction, RPTECs were sorted into DCFDA^bright^ and DCFDA^dim^ subpopulations, which were analyzed separately.

Mesenchymal stem cells were isolated from the iliac crest of systemically healthy individuals (young donor, age 5; elderly donor, age 56), which had been harvested for reconstructive bone surgery of defects within other areas of the body as described previously ([@b16]). Briefly, a small biopsy of substantia spongiosa osseum, which otherwise would have been discarded based on necessary bone for molding and re-contouring prior to insertion into the recipient site, was taken to further investigation under an Institutional Review Board-approved protocol after having obtained the parents' and the respective patient's written consent. After surgery, the bone was transferred into minimal essential medium (MEM) supplemented with 20% heat-inactivated fetal calf serum, 100 units mL^−1^ penicillin, and 100 μg mL^−1^ streptomycin (growth medium) for transportation from the operation theater to the clean room at room temperature. The biopsies were fragmented, and marrow cells were isolated from pieces (20--100 mm^3^) by centrifugation (400 *g*, 1 min). After centrifugation, the remaining pieces were treated with collagenase (2.5 mg mL^−1^ in MEM) for 2--3 h at 37°C, 20% O~2~, and 5% CO~2~. Thereafter, the specimen was again centrifuged (400 *g*, 1 min). Cells were resuspended and loaded on a Ficoll-Paque Plus® gradient and centrifuged at 2500 *g* for 30 min. Cells were harvested from the interphase (density \< 1.075 g mL^−1^), washed, and collected by centrifugation (1500 *g*, 15 min). Cells were cultured at a density of 0.2--0.5 × 10^6^ cells cm^−2^ at either 20% or 3% O~2~ in combination with 5% CO~2~ and 37°C (HeraCell240 -- Heraeus, Thermo Scientific, Vienna, Austria; Thermo Electron Forma Series II, 3110). After 24 h, the nonadherent cell fraction was removed by washing twice with PBS. After the primary culture had reached approximately 30--50% confluence, cells were washed twice with PBS and subsequently treated with 0.05% trypsin/1 m[m]{.smallcaps} EDTA for 3--5 min at 37°C. Cells were harvested, washed in MEM, and further expanded at a density of 50 cells cm^−2^.

Isolation of CD8^+^CD28^+^ and CD8^+^CD28^−^ T cells from peripheral blood of apparently healthy young (\< 35 year, *n* = 6, mean age 29, range 26--35) and elderly (\> 65 year, *n*= 10, mean age 72, range 66--87) donors was performed by preparing peripheral blood mononuclear cells (PBMCs) by Ficoll-Paque PLUS (Amersham Biosciences) density gradient centrifugation as approved by the Ethics committee of Innsbruck Medical University. CD8^+^ T cells were negatively selected from the obtained PBMC fraction by applying the magnetic separation protocol CD8^+^ T cell isolation kit II (depleting CD4, CD14, CD16, CD19, CD36, CD56, CD123, TCRγ/δ, and CD235a; Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. Subsequently, purified CD8^+^ T cells were stained with an allophycocyanin (APC)-conjugated αCD28 monoclonal antibody (mAb) and split into CD8^+^CD28^+^ and CD8^+^CD28^−^ T-cell populations using αAPC MicroBeads (Miltenyi Biotec) by passing the cell suspension through a positive selection column (LS; Miltenyi Biotec) mounted in a magnetic field. The CD8^+^CD28^−^ T-cell fraction was then re-incubated with αAPC MicroBeads and run over a fresh LS-column to increase purity. For phenotypic analysis, purified T-cell fractions were labelled with a combination of mAbs (αTCRαβ-FITC, αCD16-PE, αCD4-PerCP, αCD8-PE-Cy7, αCD28-APC, and αCD3-APC-Cy7; all BD Biosciences, Heidelberg, Germany) and analyzed on a FACSCanto II (BD Biosciences) revealing that the described isolation protocol yields population homogeneities of \> 95%.

Applying oxidative stress by tBHP treatment
-------------------------------------------

Human umbilical vein endothelial cells, PrSC, RPTEC, and CD8^+^ T lymphocytes were treated by exposure to sublethal doses of tBHP ([@b59]). Induction of senescence by repeated exposure to sublethal levels of tBHP takes 10--14 days ([@b59], and data not shown). To identify early transcriptional events involved in the senescence response, cells were analyzed 3 days after starting the treatment.

RNA Isolation, whole-genome array analysis of mRNA expression, and quantitative PCR
-----------------------------------------------------------------------------------

RNA was isolated using either Tri Reagent (Sigma-Aldrich) or performing homogenization in 4.2 [m]{.smallcaps} guanidinium thiocyanate before phenol extraction and ethanol precipitation ([@b8]), followed by LiCl precipitation at a final concentration of 4.5 [m]{.smallcaps}. Whole-genome expression analysis was carried out on GeneChip HG-U133 Plus 2.0 Arrays (Affymetrix) by MFT Services, Tuebingen, Germany.

Bioinformatics, clustering, and visualization of array data
-----------------------------------------------------------

Array raw data were normalized via CARMAweb ([@b44]) using the gcrma algorithm ([@b63]). Hierarchical clustering of samples and genes (Euclidian distance, average linkage) was performed after filtering out genes with low variance on a subset of 20 000 genes with the MeV program package ([@b48]) available online: <http://www.tm4.org/mev/>).

To evaluate the probability of observing an elevated number of under- or overexpressed gene occurrences, the distinct number of occurrences in which the gene is under- or overexpressed in a respective group of experiments was determined. The resulting gene list was ranked according to occurrences with respect to either age/senescence-related model systems or oxidative stress--derived data sets as well as a gene list of highly under- or overrepresented candidates present in both cases.

Statistical analysis to identify significant probe sets was performed as described by [@b31],[@b32];: For each probe set, a *P*-value was calculated with the cumulative binomial distribution (CBD): providing the probability P for a probe set to be as often or more often differentially expressed than the times k, it was actually differentially expressed in n experiments. The threshold for differential expression of a probe set was defined as a fold change between samples ≥ ±1.5. Applying statistical analysis based on CBD, the probability *P* that any probe set is differentially expressed with senescence or oxidative stress was defined as the average of differentially expressed probe sets in the experimental group senescence or oxidative stress divided by the number of all probe sets per whole-genome analysis.

The *q*-value was calculated for each probe set using Storey's false discovery rate (FDR) approach with the bootstrapping method ([@b53]). The robust parameter was used to make the *q*-values more accurate for small *P*-values ([@b51]). Statistical computation was carried out using the statistical framework R ([@b43]) version 2.5.1. Bioconductor *q*-value package version 1.10.0 ([@b52]) was used to calculate the FDR.

Differentially expressed genes were grouped into protein families associated with characterized pathways applying Pathway Explorer (([@b36]), available online: <https://pathwayexplorer.genome.tugraz.at/>), *P*-values were calculated from the complete expression value dataset (54 675 probe sets) with Fisher's exact test, pathway data sources: KEGG pathway database (<http://www.genome.jp/kegg/pathway.html>), GenMapp (<http://www.genmapp.org/>), Biocarta (<http://www.biocarta.com/genes/>).

Database
--------

GiSAO.db (<https://gisao.genome.tugraz.at>) is a web-based database system for storing and retrieving data of genes involved in senescence, apoptosis, and oxidative stress. The application is based on a three-tier architecture consisting of a web interface, business logic, and a database. The web interface enables data input and presentation. It was implemented by using Struts framework (<http://struts.apache.org/>) with Java Server Pages (<http://java.sun.com/products/jsp/>). The business logic, which is responsible for data processing is an Enterprise JavaBeans 3 (<http://java.sun.com/products/ejb/>) application deployed on JBoss (<http://www.jboss.org/jbossas/>) application server. The data are stored in an Oracle database, a relational database management system.

The GiSAO database contains normalized gene expression values obtained from experiments evaluated with the aid of Affymetrix arrays. Gene expression values of each experiment can be displayed and compared with the gene expression values of two or more microarray experiments. Additionally, experimental data of follow-up experiments regarding candidate genes, such as qPCR or Western Blot analysis, are entered into the GiSAO.db. Furthermore, GiSAO.db contains two types of orthologue data: orthologue data provided and updated by Affymetrix from cross reference tables linking *Saccharomyces cerevisiae*, *Caenorhabditis elegans*, *Drosophila melanogaster*, *Mus musculus* and *Homo sapiens* facilitate comparative genomic analyses, as well as orthology data computed and entered manually. Besides mRNA expression profiles, also data from proteome analysis and further validation with respect to functional analyses together with information from public resources are available for distinct candidate genes. Moreover, external links lead to orthologs of HomoloGene (<http://www.ncbi.nlm.nih.gov/homologene>) and InParanoid (<http://inparanoid.sbc.su.se/cgi-bin/index.cgi>). The gene IDs are linked to their respective database, such as Entrez Gene or RefSeq. GiSAO.db also provides gene annotation (Gene Symbol, Gene Name, etc.) and GO terms (<http://www.geneontology.org/>). Finally, KEGG pathways (<http://www.genome.jp/kegg/>) can be displayed and data can be exported in various formats.

Identification of human orthologues in *Sacharomyces cerevisiae*
----------------------------------------------------------------

Either previously assigned cross references distinctly referring to homologous gene identifiers from other species provided in the array annotation tables accompanying the Affymetrix gene chip or data from reciprocal-best-fit-protein-homology searches ([@b38]) were employed to define the closest homologous gene pair between man and yeast. Only orthologous genes, which were found nonessential after genomic deletion in yeast laboratory strains (<http://mips.helmholtz-muenchen.de/proj/eurofan/eurofan_1/b0/search/simpleSearch.html>) were selected for further functional analyses.

Lifespan analysis of gene disruption mutants of *Sacharomyces cerevisiae*
-------------------------------------------------------------------------

Experiments were carried out in BY4741 (MATa *his3Δ1 leu2Δ0 met15Δ0 ura3Δ0*) as the wild-type strain and respective null mutants, obtained from Euroscarf. Strains were grown at 28°C on SC medium containing 0.17% yeast nitrogen base (Difco), 0.5% (NH~4~)~2~SO~4~ and 30 mg L^−1^ of all amino acids (except 80 mg L^−1^ histidine and 200 mg L^−1^ leucine), 30 mg L^−1^ adenine, and 320 mg L^−1^ uracil with 2% glucose. For all experiments, yeast cells were grown at 28°C and 145 rpm. For chronological lifespan experiments, cultures were inoculated at an OD~600~ of 0.1, and aliquots were taken to perform survival plating at indicated time points.

Statistics
----------

All values were expressed as means ± standard deviation of the mean. Statistical differences of experimental scores were evaluated using Student's *t* tests. Differences were considered significant when *P* was \< 0.05.
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